Evaluation of the Natera Colorectal Cancer Screening Test in an Average Risk Population (FIND-CRC)

Study Summary

The FIND-CRC study is a prospective collection of samples and data from participants who are at average risk of developing colorectal cancer (CRC). Collected samples and data will be analyzed to evaluate the clinical performance of the Natera CRC Screening Test.

Conditions

Colo-rectal Cancer

Interventions / Drugs

View on ClinicalTrials.gov ↗

Sponsor

Study Details

Enrollment25000 participants

Primary Completion—

Lead SponsorNatera, Inc.

Data Retrieved2026-04-11 04:23:02.260847+00:00

Not financial advice. BiotechSigns data is sourced from ClinicalTrials.gov, SEC EDGAR, and other public databases for research and informational purposes only. It does not constitute investment recommendations. Always do your own due diligence before making investment decisions.